TCM Biotech International Corp. (TPEX: 4169)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.00
-1.20 (-2.03%)
Dec 18, 2024, 2:58 PM CST

TCM Biotech International Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3,4373,4371,5021,8191,7131,052
Upgrade
Market Cap Growth
-3.16%128.87%-17.43%6.17%62.78%7.85%
Upgrade
Enterprise Value
2,9843,5181,5921,9301,7411,150
Upgrade
Last Close Price
58.2057.9129.1935.8033.3520.02
Upgrade
PE Ratio
168.82185.0282.21970.9567.06161.56
Upgrade
PS Ratio
4.053.541.872.592.321.85
Upgrade
PB Ratio
3.283.262.803.513.312.06
Upgrade
P/TBV Ratio
3.193.282.853.603.412.09
Upgrade
P/FCF Ratio
72.40-30.98162.5523.80-
Upgrade
P/OCF Ratio
65.98-28.74118.6622.87-
Upgrade
EV/Sales Ratio
3.583.631.982.752.362.02
Upgrade
EV/EBITDA Ratio
62.8889.0238.95117.5734.5840.89
Upgrade
EV/EBIT Ratio
113.05157.5662.90905.8646.9883.93
Upgrade
EV/FCF Ratio
62.87-32.84172.5424.19-
Upgrade
Debt / Equity Ratio
0.120.110.290.310.250.30
Upgrade
Debt / EBITDA Ratio
2.542.713.608.662.495.12
Upgrade
Debt / FCF Ratio
2.54-3.2514.391.79-
Upgrade
Asset Turnover
0.790.890.950.880.960.72
Upgrade
Inventory Turnover
2.182.441.781.671.811.66
Upgrade
Quick Ratio
4.683.871.421.421.741.64
Upgrade
Current Ratio
6.034.952.282.673.693.48
Upgrade
Return on Equity (ROE)
2.51%2.33%3.46%0.36%4.97%1.25%
Upgrade
Return on Assets (ROA)
1.55%1.28%1.88%0.17%3.01%1.09%
Upgrade
Return on Capital (ROIC)
1.77%1.50%2.30%0.20%3.54%1.28%
Upgrade
Earnings Yield
0.59%0.54%1.22%0.10%1.49%0.62%
Upgrade
FCF Yield
1.38%-1.21%3.23%0.62%4.20%-2.20%
Upgrade
Dividend Yield
0.49%0.49%0.11%-1.05%1.94%
Upgrade
Payout Ratio
8.09%8.71%-903.20%73.59%274.17%
Upgrade
Buyback Yield / Dilution
-18.23%-8.03%-0.89%-0.42%0.03%1.33%
Upgrade
Total Shareholder Return
-17.74%-7.54%-0.77%-0.42%1.08%3.27%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.